Skip to main content

Table 1 Kaplan–Meier analysis of clinical GBM patients

From: Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma

Clinicopathologic variables

Number

Average survival

P value

All patients

45

16.005 ± 2.360

 

Gender

 Male

24

13.786 ± 2.595

0.518

 Female

21

18.087 ± 3.903

Age at diagnosis

 < 55

24

19.163 ± 4.097

0.501

 ≥ 55

21

13.148 ± 1.726

KPS

 < 70

11

8.273 ± 2.149

0.018*

 ≥ 70

34

16.005 ± 2.360

Headache

 Yes

21

12.551 ± 1.532

0.775

 No

24

17.104 ± 3.520

Intracranial infection

 Yes

3

6 ± 4.041

0.05

 No

42

16.752 ± 2.489

Multiple lobe lesions

 Yes

11

15.697 ± 3.715

0.727

 No

34

15.913 ± 2.815

RND1 expression

 High

22

20.801 ± 3.912

0.007*

 Low

23

10.947 ± 1.828